The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study
Open Access
- 11 April 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0296863
Abstract
Introduction: Known to have pleiotropic functions, high-density lipoprotein (HDL) helps to regulate systemic inflammation during sepsis. As preserving HDL-C level is a promising therapeutic strategy for sepsis, the interaction between HDL and sepsis worth further investigation. This study aimed to determine the impact of sepsis on HDL’s anti-inflammatory capacity and explore its correlations with disease severity and laboratory parameters. Methods and materials: We enrolled 80 septic subjects admitted to the intensive care unit and 50 controls admitted for scheduled coronary angiography in this cross-sectional study. We used apolipoprotein-B depleted (apoB-depleted) plasma to measure the anti-inflammatory capacity of HDL-C. ApoB-depleted plasma’s anti-inflammatory capacity is defined as its ability to suppress tumor necrosis factor-α–induced vascular cell adhesion molecule-1 (VCAM-1) expression in human umbilical-vein endothelial cells. A subgroup analysis was conducted to investigate in septic subjects according to disease severity. Results: ApoB-depleted plasma’s anti-inflammatory capacity was reduced in septic subjects relative to controls (VCAM-1 mRNA fold change: 50.1% vs. 35.5%; p < 0.0001). The impairment was more pronounced in septic subjects with than in those without septic shock (55.8% vs. 45.3%, p = 0.0022). Both associations were rendered non-significant with the adjustment for the HDL-C level. In sepsis patients, VCAM-1 mRNA fold change correlated with the SOFA score (Spearman’s r = 0.231, p = 0.039), lactate level (r = 0.297, p = 0.0074), HDL-C level (r = –0.370, p = 0.0007), and inflammatory markers (C-reactive protein level: r = 0.441, p r = 0.353, p = 0.0013). Conclusion: ApoB-depleted plasma’s anti-inflammatory capacity is reduced in sepsis patients and this association depends of HDL-C concentration. In sepsis patients, this capacity correlates with disease severity and inflammatory markers. These findings explain the prognostic role of the HDL-C level in sepsis and indirectly support the rationale for targeting HDL-C as sepsis treatment.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 106-2314-B-350-001-MY3)
- Ministry of Health and Welfare (MOHW106-TDU-B-211-113001)
- Ministry of Science and Technology, Taiwan (MOST 108-2633-B-009-001)
- Taipei Veterans General Hospital (V105C-207, V106C-045, V108C-195, V109B-010, and V109D50-003-MY3-1)
This publication has 50 references indexed in Scilit:
- Subtypes and Mimics of SepsisCritical Care Clinics, 2022
- Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signaturesEBioMedicine, 2022
- Anti-inflammatory HDL effects are impaired in atrial fibrillationHeart and Vessels, 2021
- HDL cholesterol: reappraisal of its clinical relevanceClinical Research in Cardiology, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Ethnic Variation in Lipid Profile and Its Associations with Body Composition and Diet: Differences Between Iranians, Indians and Caucasians Living in AustraliaJournal of Immigrant and Minority Health, 2016
- HDL in Infectious Diseases and Sepsis2014
- The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterolClinica Chimica Acta, 2014
- Inflammation modulates human HDL composition and function in vivoAtherosclerosis, 2012
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007